NCT04361032
Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia
Phase: Phase 3
Role: Collaborator
Start: Sep 4, 2020
Completion: Oct 4, 2020